Literature DB >> 17321620

Tumour and target volumes in permanent prostate brachytherapy: a supplement to the ESTRO/EAU/EORTC recommendations on prostate brachytherapy.

Carl Salembier1, Pablo Lavagnini, Philippe Nickers, Paola Mangili, Alex Rijnders, Alfredo Polo, Jack Venselaar, Peter Hoskin.   

Abstract

The aim of this paper is to supplement the GEC/ESTRO/EAU recommendations for permanent seed implantations in prostate cancer to develop consistency in target and volume definition for permanent seed prostate brachytherapy. Recommendations on target and organ at risk (OAR) definitions and dosimetry parameters to be reported on post implant planning are given.

Entities:  

Mesh：

Year:  2007        PMID： 17321620     DOI： 10.1016/j.radonc.2007.01.014

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN： 0167-8140            Impact factor:   6.280


  57 in total

1.  Institutional patient accrual volume and the treatment quality of I‑125 prostate seed implantation in a Japanese nationwide prospective cohort study.

Authors:  Katsumasa Nakamura; Saiji Ohga; Atsunori Yorozu; Shiro Saito; Takashi Kikuchi; Takushi Dokiya; Masanori Fukushima; Hidetoshi Yamanaka
Journal:  Strahlenther Onkol       Date:  2018-12-05       Impact factor: 3.621

2.  Comparison of seed brachytherapy or external beam radiotherapy (70 Gy or 74 Gy) in 919 low-risk prostate cancer patients.

Authors:  G Goldner; R Pötter; J J Battermann; M P Schmid; C Kirisits; S Sljivic; M van Vulpen
Journal:  Strahlenther Onkol       Date:  2012-02-22       Impact factor: 3.621

3.  [Benefit assessment by the Federal Joint Committee: assessment of treatment strategies for low risk prostate cancer].

Authors:  M Schmedders; S Janatzek; B Zimmer
Journal:  Urologe A       Date:  2011-08       Impact factor: 0.639

Review 4.  The evolution of brachytherapy for prostate cancer.

Authors:  Nicholas G Zaorsky; Brian J Davis; Paul L Nguyen; Timothy N Showalter; Peter J Hoskin; Yasuo Yoshioka; Gerard C Morton; Eric M Horwitz
Journal:  Nat Rev Urol       Date:  2017-06-30       Impact factor: 14.432

5.  Feasibility of vibro-acoustography with a quasi-2D ultrasound array transducer for detection and localizing of permanent prostate brachytherapy seeds: a pilot ex vivo study.

Authors:  Mohammad Mehrmohammadi; Azra Alizad; Randall R Kinnick; Brian J Davis; Mostafa Fatemi
Journal:  Med Phys       Date:  2014-09       Impact factor: 4.071

Review 6.  Recent developments and best practice in brachytherapy treatment planning.

Authors:  C D Lee
Journal:  Br J Radiol       Date:  2014-06-02       Impact factor: 3.039

7.  AAPM recommendations on dose prescription and reporting methods for permanent interstitial brachytherapy for prostate cancer: report of Task Group 137.

Authors:  Ravinder Nath; William S Bice; Wayne M Butler; Zhe Chen; Ali S Meigooni; Vrinda Narayana; Mark J Rivard; Yan Yu
Journal:  Med Phys       Date:  2009-11       Impact factor: 4.071

8.  Technical and dosimetric aspects of iodine-125 seed reimplantation in suboptimal prostate implants.

Authors:  L G Marcu; J M Lawson
Journal:  Br J Radiol       Date:  2013-03-21       Impact factor: 3.039

Review 9.  [The importance of pathology in the German prostate cancer study PREFERE].

Authors:  G Kristiansen; M Stöckle; P Albers; H Schmidberger; P Martus; S Wellek; M Härter; R Bussar-Maatz; T Wiegel
Journal:  Pathologe       Date:  2013-09       Impact factor: 1.011

10.  Radiation safety of receptive anal intercourse with prostate cancer patients treated with low-dose-rate brachytherapy.

Authors:  Nicola J Nasser; Gil'ad N Cohen; Lawrence T Dauer; Michael J Zelefsky
Journal:  Brachytherapy       Date:  2016-05-12       Impact factor: 2.362
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.